• Hunan Prevention and Treatment Central for Occupational Diseases, Changsha, Hunan 410007, P.R.China;
LI Ying, Email: liying9858@163.com
Export PDF Favorites Scan Get Citation

Objective  To evaluate therapeutic efficacy and safety of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) inhalation in patients with recurrent pulmonarv alveolar proteinosis (PAP). Methods  Three cases of recurrent PAP were treated by GM-CSF inhalation after whole lung lavage. The clinical data of the pulmonary function and SpO 2, the clinical symptoms and pulmonary lesions were compared before and after treatment. Results  The pulmonary function and manifestations were improved obviously after GM-CSF inhalation. Also the ground-glass opacity was improved in high-resolution CT. The pulmonary function and SpO 2 increased obviously after received GM-CSF inhalation. There were no any adverse reactions in 3 cases. Conclusion  GM-CSF inhalation therapy is effective and safe in recurrent PAP, but the long-term effect remains to be seen.

Citation: LI Ying, LIU Lang, ZHANG Xiaohua, LUO Guangming, YAN Wei, YANG Long. Therapeutic efficacy of GM-CSF inhalation in patients with recurrent pulmonary alveolar proteinosis. Chinese Journal of Respiratory and Critical Care Medicine, 2017, 16(3): 271-273. doi: 10.7507/1671-6205.201608008 Copy

  • Previous Article

    Chronic eosinophilic pneumonia: five cases report
  • Next Article

    Intraperitoneal instillation versus intratracheal injection of lipopolysaccharide: differences in establishment of acute lung injury model